BioCentury
ARTICLE | Company News

Roche sales and marketing update

September 7, 2015 7:00 AM UTC

France’s Minister of Social Affairs and Health approved reimbursement for the off-label use of Avastin bevacizumab from Roche to treat age-related macular degeneration (AMD). In June, the French Nati...